Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction

NCT06080802 is registered in ClinicalTrials.gov with October University for Modern Sciences and Arts as lead sponsor.

NCT NCT06080802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06080802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction
Lead sponsor
October University for Modern Sciences and Arts
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 1, 2023
Completion date
December 1, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, heart failure with preserved ejection fraction